Skip to main content
S 4010 116th Congress Senate Health Child health Drug safety, medical device, and laboratory regulation Health programs administration and funding Health promotion and preventive care Infectious and parasitic diseases

Creating Hope Reauthorization Act

Introduced: June 18, 2020 See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 18, 2020
Introduced in Senate
Jun 18, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
 Plain-English summary Congressional Research Service

Creating Hope Reauthorization Act

This bill permanently reauthorizes a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)

What's happening now June 18, 2020

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 1